| Abstrakt: |
Delays in breast cancer surgery due to the COVID-19 pandemic could lead to an additional 2,797 deaths over the next decade according to Kantar Health, a leading global healthcare data, analytics and research provider, Delays in treatments could result in an additional $376 million in treatment costs over that time period due to more patients developing metastasis. The analysis, released as part of World Breast Cancer Awareness Month, is based on Kantar Health’s CancerMPact® Patient Metrics database, a decision support resource for oncology market analysis, strategic planning and identifying commercial opportunities. [ABSTRACT FROM PUBLISHER] |
